COVID-19 vaccine provides effective protection against Omicron pregnancy risks
Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm’s China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.
(photo credit: REUTERS/FLORENCE LO)